Literature DB >> 31128300

Role of AHR in the control of GBM-associated myeloid cells.

Galina Gabriely1, Francisco J Quintana2.   

Abstract

Glioblastoma (GBM) is an aggressive and incurable brain tumor; its malignancy has been associated with the activity of tumor infiltrating myeloid cells. Myeloid cells play important roles in the tumor control by the immune response, but also in tumor progression. Indeed, GBM exploits multiple mechanisms to recruit and modulate myeloid cells. The Aryl Hydrocarbon Receptor (AHR) is a ligand activated transcription factor implicated in the regulation of myeloid cells. In this review, we will summarize current knowledge on the AHR role in the control of myeloid cells and its impact on GBM pathogenesis.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  AHR; Cancer; Glioblastoma; Immune suppression; Myeloid cells

Mesh:

Substances:

Year:  2019        PMID: 31128300      PMCID: PMC6874737          DOI: 10.1016/j.semcancer.2019.05.014

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  86 in total

1.  Dioxin receptor is a ligand-dependent E3 ubiquitin ligase.

Authors:  Fumiaki Ohtake; Atsushi Baba; Ichiro Takada; Maiko Okada; Kei Iwasaki; Hiromi Miki; Sayuri Takahashi; Alexander Kouzmenko; Keiko Nohara; Tomoki Chiba; Yoshiaki Fujii-Kuriyama; Shigeaki Kato
Journal:  Nature       Date:  2007-03-29       Impact factor: 49.962

2.  Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism.

Authors:  Nam Trung Nguyen; Akihiro Kimura; Taisuke Nakahama; Ichino Chinen; Kazuya Masuda; Keiko Nohara; Yoshiaki Fujii-Kuriyama; Tadamitsu Kishimoto
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-01       Impact factor: 11.205

Review 3.  The Aryl Hydrocarbon Receptor: Connecting Immunity to the Microenvironment.

Authors:  Rahul Shinde; Tracy L McGaha
Journal:  Trends Immunol       Date:  2018-11-05       Impact factor: 16.687

4.  Distribution and characterization of microglia/macrophages in human brain tumors.

Authors:  W Roggendorf; S Strupp; W Paulus
Journal:  Acta Neuropathol       Date:  1996-09       Impact factor: 17.088

5.  Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy.

Authors:  Stefani Spranger; Daisy Dai; Brendan Horton; Thomas F Gajewski
Journal:  Cancer Cell       Date:  2017-05-08       Impact factor: 31.743

6.  A novel low molecular weight inhibitor of dendritic cells and B cells blocks allergic inflammation.

Authors:  Peter Ettmayer; Peter Mayer; Frank Kalthoff; Wolfgang Neruda; Nathalie Harrer; Gabriella Hartmann; Michelle M Epstein; Volker Brinkmann; Christoph Heusser; Maximilian Woisetschläger
Journal:  Am J Respir Crit Care Med       Date:  2005-12-30       Impact factor: 21.405

Review 7.  Malignant glioma biology: role for TGF-beta in growth, motility, angiogenesis, and immune escape.

Authors:  M Platten; W Wick; M Weller
Journal:  Microsc Res Tech       Date:  2001-02-15       Impact factor: 2.769

8.  Increased glioma growth in mice depleted of macrophages.

Authors:  Hugo Galarneau; Jérôme Villeneuve; Geneviève Gowing; Jean-Pierre Julien; Luc Vallières
Journal:  Cancer Res       Date:  2007-09-15       Impact factor: 12.701

9.  Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor.

Authors:  Francisco J Quintana; Alexandre S Basso; Antonio H Iglesias; Thomas Korn; Mauricio F Farez; Estelle Bettelli; Mario Caccamo; Mohamed Oukka; Howard L Weiner
Journal:  Nature       Date:  2008-03-23       Impact factor: 49.962

10.  Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors.

Authors:  Michele De Palma; Mary Anna Venneri; Rossella Galli; Lucia Sergi Sergi; Letterio S Politi; Maurilio Sampaolesi; Luigi Naldini
Journal:  Cancer Cell       Date:  2005-09       Impact factor: 31.743

View more
  8 in total

Review 1.  The Oncogenesis of Glial Cells in Diffuse Gliomas and Clinical Opportunities.

Authors:  Qiyuan Zhuang; Hui Yang; Ying Mao
Journal:  Neurosci Bull       Date:  2022-10-13       Impact factor: 5.271

Review 2.  A Conceptual Framework for Inducing T Cell-Mediated Immunity Against Glioblastoma.

Authors:  Sascha Marx; Anze Godicelj; Kai W Wucherpfennig
Journal:  Semin Immunopathol       Date:  2022-05-03       Impact factor: 11.759

Review 3.  The Gut-CNS Axis in Multiple Sclerosis.

Authors:  Atsushi Kadowaki; Francisco J Quintana
Journal:  Trends Neurosci       Date:  2020-07-07       Impact factor: 13.837

Review 4.  Glial and myeloid heterogeneity in the brain tumour microenvironment.

Authors:  Brian M Andersen; Camilo Faust Akl; Michael A Wheeler; E Antonio Chiocca; David A Reardon; Francisco J Quintana
Journal:  Nat Rev Cancer       Date:  2021-09-28       Impact factor: 69.800

Review 5.  Hypomethylating Agents and Immunotherapy: Therapeutic Synergism in Acute Myeloid Leukemia and Myelodysplastic Syndromes.

Authors:  Kah Keng Wong; Rosline Hassan; Nik Soriani Yaacob
Journal:  Front Oncol       Date:  2021-02-25       Impact factor: 6.244

Review 6.  Microbiota-Mediated Immune Regulation in Atherosclerosis.

Authors:  Sahar Eshghjoo; Arul Jayaraman; Yuxiang Sun; Robert C Alaniz
Journal:  Molecules       Date:  2021-01-01       Impact factor: 4.411

7.  Tryptophan metabolism is inversely regulated in the tumor and blood of patients with glioblastoma.

Authors:  Verena Panitz; Saša Končarević; Ahmed Sadik; Dennis Friedel; Tobias Bausbacher; Saskia Trump; Vadim Farztdinov; Sandra Schulz; Philipp Sievers; Stefan Schmidt; Ina Jürgenson; Stephan Jung; Karsten Kuhn; Irada Pflüger; Suraj Sharma; Antje Wick; Pauline Pfänder; Stefan Selzer; Philipp Vollmuth; Felix Sahm; Andreas von Deimling; Ines Heiland; Carsten Hopf; Peter Schulz-Knappe; Ian Pike; Michael Platten; Wolfgang Wick; Christiane A Opitz
Journal:  Theranostics       Date:  2021-09-03       Impact factor: 11.556

Review 8.  The aryl hydrocarbon receptor and the gut-brain axis.

Authors:  João Vitor Mahler; Pedro Henrique Fonseca-Castro; Andreia Barroso; Francisco J Quintana
Journal:  Cell Mol Immunol       Date:  2021-01-06       Impact factor: 22.096

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.